12 weeks, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of ME315 (Morus alba extract) on serum cholesterol
Not Applicable
Completed
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0002108
- Lead Sponsor
- Inje University Seoul Paik Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Total Cholesterol 170~250 mg/dl or LDL-Cholesterol 130~189 (20yrs~60yrs)
Exclusion Criteria
Subjects who has taken medicines, health functional foods within 3 months for improvement of Cholesterol level.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total cholesterol ;LDL-cholesterol ;HDL- cholesterol
- Secondary Outcome Measures
Name Time Method Adverse Event